Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) had its target price hoisted by equities research analysts at Truist Financial from $16.00 to $17.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has a “hold” rating on the business services provider’s stock. Truist Financial’s price target would indicate a potential downside of 0.64% from the stock’s current price.
CCRN has been the subject of a number of other reports. Benchmark decreased their target price on Cross Country Healthcare from $21.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Barrington Research decreased their target price on Cross Country Healthcare from $24.00 to $21.00 and set an “outperform” rating for the company in a research note on Monday, May 6th. Six research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, Cross Country Healthcare currently has a consensus rating of “Hold” and an average price target of $21.00.
Check Out Our Latest Research Report on CCRN
Cross Country Healthcare Stock Down 2.5 %
Shares of Cross Country Healthcare stock opened at $17.11 on Thursday. The firm has a market cap of $594.91 million, a P/E ratio of 13.16, a P/E/G ratio of 2.51 and a beta of 0.63. Cross Country Healthcare has a fifty-two week low of $12.87 and a fifty-two week high of $26.17. The business has a 50-day moving average price of $14.76 and a 200 day moving average price of $17.04.
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The business services provider reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.04). The firm had revenue of $339.77 million during the quarter, compared to the consensus estimate of $334.75 million. Cross Country Healthcare had a net margin of 0.54% and a return on equity of 7.17%. The firm’s quarterly revenue was down 37.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.69 earnings per share. As a group, equities research analysts anticipate that Cross Country Healthcare will post 0.73 earnings per share for the current year.
Insider Transactions at Cross Country Healthcare
In other news, insider Marc S. Krug sold 13,657 shares of the business’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $14.82, for a total transaction of $202,396.74. Following the completion of the transaction, the insider now directly owns 36,020 shares in the company, valued at $533,816.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other Cross Country Healthcare news, insider Marc S. Krug sold 13,657 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $14.82, for a total value of $202,396.74. Following the completion of the sale, the insider now directly owns 36,020 shares in the company, valued at $533,816.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Phillip Lyn Noe sold 9,646 shares of the company’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $14.19, for a total value of $136,876.74. Following the completion of the sale, the insider now owns 10,162 shares of the company’s stock, valued at $144,198.78. The disclosure for this sale can be found here. Insiders own 4.90% of the company’s stock.
Institutional Investors Weigh In On Cross Country Healthcare
A number of institutional investors have recently added to or reduced their stakes in the company. Versor Investments LP lifted its position in Cross Country Healthcare by 20.4% in the second quarter. Versor Investments LP now owns 12,400 shares of the business services provider’s stock worth $172,000 after purchasing an additional 2,100 shares during the period. nVerses Capital LLC acquired a new stake in Cross Country Healthcare in the second quarter worth approximately $50,000. Bank of New York Mellon Corp increased its holdings in shares of Cross Country Healthcare by 3.1% in the second quarter. Bank of New York Mellon Corp now owns 304,956 shares of the business services provider’s stock valued at $4,221,000 after buying an additional 9,090 shares in the last quarter. SummerHaven Investment Management LLC increased its holdings in shares of Cross Country Healthcare by 3.8% in the second quarter. SummerHaven Investment Management LLC now owns 28,376 shares of the business services provider’s stock valued at $393,000 after buying an additional 1,032 shares in the last quarter. Finally, Raymond James & Associates increased its holdings in shares of Cross Country Healthcare by 0.7% in the second quarter. Raymond James & Associates now owns 165,324 shares of the business services provider’s stock valued at $2,288,000 after buying an additional 1,155 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also
Receive News & Ratings for Cross Country Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Cross Country Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
